However, the initial Phase I study of TA-NIC will merely assess its safety and tolerability at different doses, and researchers still have several years work ahead of them to prove the efficacy of the product.
However, the initial Phase I study of TA-NIC will merely assess its safety and tolerability at different doses, and researchers still have several years work ahead of them to prove the efficacy of the product.
据悉，目前这种疫苗的第一步试验还停留在用量安全标准上，科学家仍需要数年的时间来提高疫苗的效力。